IMU 1.64% 6.0¢ imugene limited

March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) : ALA-101...

  1. 188,817 Posts.
    lightbulb Created with Sketch. 2765

    March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) :

    • ALA-101 AND ONCARLYTICS COLLABORATION UPDATE
    • IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
    • PARTNERSHIP TO COMBINE ALA‐101 AND ONCARLYTICS HAS ENDED
    • NO FINANCIAL IMPACT FROM CESSATION OF COLLABORATION FOR AROVELLA
    • COLLABORATION WILL BE TERMINATED WITH IMMEDIATE EFFECT
    • TERMINATION WILL NOT IMPACT CO'S DEVELOPMENT OF ALA‐101 FOR CD19‐POSITIVE BLOOD CANCERS

    (([email protected];;))

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.001(1.64%)
Mkt cap ! $439.1M
Open High Low Value Volume
6.2¢ 6.4¢ 6.0¢ $445.6K 7.286M

Buyers (Bids)

No. Vol. Price($)
18 476260 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 654584 12
View Market Depth
Last trade - 13.26pm 06/06/2024 (20 minute delay) ?
Last
6.1¢
  Change
-0.001 ( 2.10 %)
Open High Low Volume
6.2¢ 6.4¢ 6.0¢ 1645601
Last updated 13.40pm 06/06/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.